InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CI1 +AXM CAQ CBD CDB CPS FLR GCN GNV GOA GRG HDX KFG SEQ OCE PPN QTG RCI RRI SHK UXA | Ann: Suspension from Official Quotation | 01/11/12 | 74 | 32K | |||
|
|||||||
RCI | Ann: Removal from Official List - close 15/10/201 | 12/10/12 | 0 | 401 | |||
|
|||||||
RCI | Ann: Final Director's Interest Notice | 03/10/12 | 0 | 442 | |||
|
|||||||
RCI | Ann: 2012 Annual Report | 03/10/12 | 0 | 442 | |||
|
|||||||
RCI | Ann: Response to ASX Query | 02/10/12 | 0 | 456 | |||
|
|||||||
RCI | Ann: Suspension from Official Quotation at close | 27/09/12 | 0 | 253 | |||
|
|||||||
RCI | Ann: Compulsory acquisition notice | 26/09/12 | 0 | 232 | |||
|
|||||||
RCI | Ann: Initial Director's Interest Notice | 25/09/12 | 0 | 269 | |||
|
See All Discussions